Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2098.6000 -57.60 (-2.67%)

NSE Aug 29, 2025 15:31 PM

31.24% Gain from 52W Low

Volume: 50,682

Caplin Point Laboratories Ltd.

14 May 2025

2098.60

-2.67%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Five Interesting Stocks Today - August 29, 2025

The Baseline | 29 Aug 2025, 05:09PM

Market closes lower, Reliance Jio Infocomm to list by first half of 2026

Trendlyne Marketwatch | 29 Aug 2025, 03:59PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets